Results 91 to 100 of about 2,258 (135)

Facial herpes vegetans in a person living with human immunodeficiency virus with undetectable viral load. [PDF]

JAAD Case Rep
Antohi DR, Hossain O, Toker M, Ghias M, Occidental M, Amin B, Wu B.   +6 more
europepmc   +1 more source

Post-herpetic Abdominal Pseudohernia With Underrecognized Characteristics of Male Predominance and Co-occurring Fatal Visceral Herniation: A Case Report and a Literature Review. [PDF]

Cureus
Kishimoto C, Kitano Y, Matsuda-Okazaki T, Oyama N, Hasegawa M.   +4 more
europepmc   +1 more source

Integrated Transcriptomic and Machine Learning Analysis Identifies EAF2 as a Diagnostic Biomarker and Key Pathogenic Factor in Parkinson's Disease. [PDF]

Int J Gen Med
Peng H, Cheng Y, Chen Q, Qin L.
europepmc   +1 more source

Venetoclax/FluBu2 RIC transplant followed by all-oral venetoclax/decitabine maintenance for poor-risk MDS/AML. [PDF]

Blood Adv
Garcia JS, Kim HT, Murdock HM, Bosch-Vilaseca A, Panaro KM, Lim F, Fiorilla J, Auriemma E, Brock J, Gooptu M, Ho VT, Cutler CS, Shapiro R, Kelkar AH, Abel GA, DeAngelo DJ, Stone RM, Bat-Erdene D, Ryan J, Fell G, Letai A, Ritz J, Lindsley RC, Antin JH, Soiffer RJ.   +24 more
europepmc   +1 more source

Chimeric antigen receptor T-cell therapy and fludarabine: precision dosing imperatives. [PDF]

Blood Adv
Wicha SG, Wansing EMA, Dadkhah A, Ayuk FA, Kröger NM, Langebrake C.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Toxicity of Vidarabine

JAMA: The Journal of the American Medical Association, 1979
To the Editor.— Previously we described two patients who were treated with vidarabine (adenine arabinoside) for chronic hepatitis B infection (239:1648, 1978). Since this report we have treated 13 other patients with similar regimens. A summary of side effects related to this drug in all 15 patients follows.
S L, Sacks, J L, Smith, R B, Pollard, V, Sawhney, A S, Mahol, P, Gregory, T C, Merigan, W S, Robinson   +7 more
openaire   +2 more sources

Hematologic Abnormalities Associated with Vidarabine

Drug Intelligence & Clinical Pharmacy, 1984
A report of hematologic abnormalities associated with administration of vidarabine in a neonate is presented. High doses of vidarabine (30 mg/kg/d) for the treatment of herpes simplex infection may have caused a decrease in hematocrit and platelet count. This case demonstrates the need to monitor hematologic indices during administration of vidarabine.
R A, Lyon, S, Swigart
openaire   +2 more sources

Stability-Indicating Assay for Vidarabine

Journal of Pharmaceutical Sciences, 1979
A physicochemical procedure for the analysis of vidarabine in aqueous parenteral formulations was needed to assure potency and to define stability. Concurrent with the development of this method, its decomposition products and route in aqueous solution were determined.
W H, Hong, D H, Szulczewski
openaire   +2 more sources

Treatment of Vaccinial Keratitis With Vidarabine

Archives of Ophthalmology, 1976
Vaccinial epithelial keratitis was produced in rabbits. When the therapeutic effect of vidarabine on the experimentally-induced disease was evaluated and compared to the effect of idoxuridine, vidarabine was found to be highly effective, substantially more effective than idoxuridine, and nontoxic to the eye.
R A, Hyndiuk, M, Okumoto, R A, Damiano, M, Valenton, G, Smolin   +4 more
openaire   +2 more sources

Vidarabine-Loaded Nanoparticles: A Physicochemical Study

Pharmaceutical Research, 1990
The chemical reaction of vidarabine (VIDA) with isohexyl cyanoacrylate nanoparticles in a pH-dependent fashion occurs only in the presence of dioctylsulfosuccinate (DOSS). The formation of an ion pair with DOSS allows a better contact of VIDA with the monomer during the polymerization process taking place in micelles.
V, Guise, J Y, Drouin, J, Benoit, J, Mahuteau, P, Dumont, P, Couvreur   +5 more
openaire   +2 more sources